DaVita Inc. (DVA): Price and Financial Metrics

DaVita Inc. (DVA): $133.78

10.63 (+8.63%)

POWR Rating

Component Grades














  • DVA scores best on the Stability dimension, with a Stability rank ahead of 80.67% of US stocks.
  • The strongest trend for DVA is in Stability, which has been heading up over the past 31 weeks.
  • DVA's current lowest rank is in the Sentiment metric (where it is better than 38.2% of US stocks).

DVA Stock Summary

  • Davita Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 96.66% of US listed stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 11.16 for Davita Inc; that's greater than it is for 93.16% of US stocks.
  • In terms of volatility of its share price, DVA is more volatile than merely 12.78% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Davita Inc are FRTA, CCB, TPX, HBAN, and JBL.
  • DVA's SEC filings can be seen here. And to visit Davita Inc's official web site, go to www.davita.com.

DVA Valuation Summary

  • DVA's price/sales ratio is 1.1; this is 90.72% lower than that of the median Healthcare stock.
  • DVA's price/sales ratio has moved down 0.1 over the prior 243 months.
  • Over the past 243 months, DVA's price/sales ratio has gone down 0.1.

Below are key valuation metrics over time for DVA.

Stock Date P/S P/B P/E EV/EBIT
DVA 2020-05-26 0.8 4.9 10.5 12.2
DVA 2019-07-29 0.9 2.6 76.4 25.9
DVA 2015-08-24 1.2 3.1 35.3 21.9
DVA 2011-12-23 1.1 3.6 17.9 12.4
DVA 2010-08-04 1.0 2.8 14.7 10.2
DVA 2007-12-14 1.1 3.6 16.0 10.6

DVA Growth Metrics

  • Its 2 year cash and equivalents growth rate is now at 232.54%.
  • The year over year cash and equivalents growth rate now stands at -28.72%.
  • The 4 year price growth rate now stands at 7.69%.
DVA's revenue has moved down $2,046,897,000 over the prior 67 months.

The table below shows DVA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 11,529.37 1,772.951 771.452
2020-12-31 11,550.6 1,979.028 773.642
2020-09-30 11,543.87 2,174.76 844.74
2020-06-30 11,523.88 2,332.743 829.336
2020-03-31 11,486.6 2,291.432 901.285
2019-12-31 11,388.48 2,072.355 810.981

DVA Price Target

For more insight on analysts targets of DVA, see our DVA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $126.43 Average Broker Recommendation 1.94 (Hold)

DVA Stock Price Chart Interactive Chart >

Price chart for DVA

DVA Price/Volume Stats

Current price $133.78 52-week high $136.48
Prev. close $123.15 52-week low $80.85
Day low $127.00 Volume 2,133,700
Day high $136.48 Avg. volume 705,164
50-day MA $121.27 Dividend yield N/A
200-day MA $113.08 Market Cap 14.21B

DaVita Inc. (DVA) Company Bio

DaVita Healthcare Partners delivers dialysis services to patients with chronic kidney failure and end stage renal disease. The company was founded in 1994 and is based in Denver, Colorado.

DVA Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$133.78$150.69 23%

We started the process of determining a valid price forecast for Davita Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Davita Inc ranked in the 59th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of Davita Inc, consider:

  • 54% of the company's capital comes from equity, which is greater than just 18.22% of stocks in our cash flow based forecasting set.
  • Davita Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 2.66% of tickers in our DCF set.
  • Relative to other stocks in its sector (Healthcare), Davita Inc has a reliance on debt greater than 89.52% of them.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

AMPH, HZNP, ESMC, JAZZ, and PRAH can be thought of as valuation peers to DVA, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

DVA Latest News Stream

Event/Time News Detail
Loading, please wait...

DVA Latest Social Stream

Loading social stream, please wait...

View Full DVA Social Stream

Latest DVA News From Around the Web

Below are the latest news stories about Davita Inc that investors may wish to consider to help them evaluate DVA as an investment opportunity.

Is DaVita Inc. (NYSE:DVA) Trading At A 37% Discount?

Today we will run through one way of estimating the intrinsic value of DaVita Inc. ( NYSE:DVA ) by taking the expected...

Yahoo | July 30, 2021

The 7 Best Warren Buffett Stocks to Buy in August and Hold for Years

These Buffett stocks are suitable for a wide range of retail portfolios.

Tezcan Gecgil on InvestorPlace | July 29, 2021

DaVita (DVA) to Report Q2 Earnings: What's in the Offing?

Sustained momentum with respect to U.S. dialysis revenue per treatment is likely to have aided DaVita's (DVA) top line in the second quarter despite ongoing pandemic-led higher PPE costs.

Yahoo | July 28, 2021

DaVita HealthCare (DVA) Earnings Expected to Grow: Should You Buy?

DaVita HealthCare (DVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 27, 2021

15 Best Warren Buffett Stocks to Buy Now

In this article, we discuss the 15 best Warren Buffett stocks to buy now. If you want to skip our detailed analysis of Buffett’s history, investment philosophy, and performance, go directly to the 5 Best Warren Buffett Stocks to Buy Now. Warren Buffett, the CEO of Berkshire Hathaway and the Oracle of Omaha is one […]

Yahoo | July 26, 2021

Read More 'DVA' Stories Here

DVA Price Returns

1-mo 10.69%
3-mo 5.50%
6-mo 22.53%
1-year 61.34%
3-year 83.18%
5-year 73.83%
YTD 13.95%
2020 56.47%
2019 45.80%
2018 -28.78%
2017 12.54%
2016 -7.90%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8454 seconds.